Foghorn Therapeutics (FHTX) Treasury Shares (2019)

Foghorn Therapeutics (FHTX) recorded quarterly Treasury Shares of $891894.0 in Q4 2019.

Foghorn Therapeutics (FHTX) Treasury Shares (2019) Analysis & Trends

Foghorn Therapeutics' Treasury Shares history runs 1 years deep, the most recent figure standing at $891894.0 for Q4 2019.

In Q4 2019, Treasury Shares changed N/A year-over-year to $891894.0; the TTM figure through Dec 2019 stood at $891894.0 (changed N/A YoY), while the FY2019 annual figure was $891894.0, changed N/A from the prior year.
Treasury Shares was $891894.0 for Q4 2019 at Foghorn Therapeutics.
In the past five years, Treasury Shares ranged from a high of $891894.0 in Q4 2019 to a low of $891894.0 in Q4 2019.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	1.48 Mn
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	700,000.00
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Foghorn Therapeutics	282.33 Mn	193.42 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2019	891,894.00
Dec 31, 2019	891,894.00